Search research articles
Contact Us
Filters
Showing results (261-270 of 280) with videos related to
Page
of 28
Sort By:
Gut
|
June 24, 2025
Rice-derived recombinant human serum albumin as an alternative to human plasma for patients with decompensated liver cirrhosis: a randomised, double-blind, positive-controlled and non-inferiority trial
Junqi Niu, Yanhang Gao, Guiqiang Wang, et al.
Clinical and Molecular Hepatology
|
January 22, 2025
Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0
Di Wu, Jia-Horng Kao, Teerha Piratvisuth, et al.
EMBO Reports
|
July 10, 2020
The deubiquitinase USP44 promotes Treg function during inflammation by preventing FOXP3 degradation
Jing Yang, Ping Wei, Joseph Barbi, et al.
Scientific Reports
|
July 18, 2020
High prevalence of Clonorchis sinensis infections and coinfection with hepatitis virus in riverside villages in northeast China
Yanhang Gao, Yanqing Li, Xiaowen Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 6, 2021
Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 Trial
Yanhang Gao, Fei Kong, Xinwen Song, et al.
The Journal of Infection
|
February 23, 2025
Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trial
Mingyuan Zhang, Yanhang Gao, Fei Kong, et al.
Journal of Gastroenterology and Hepatology
|
October 5, 2013
Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection
Huiying Rao, Lai Wei, Juan Carlos Lopez-Talavera, et al.
Nature Medicine
|
November 7, 2025
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial
Grace Lai-Hung Wong, Man-Fung Yuen, Bingliang Lin, et al.
Emerging Microbes & Infections
|
November 18, 2022
Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China
Hongqin Xu, Hongyan Li, Hailong You, et al.
Journal of Gastroenterology and Hepatology
|
August 26, 2020
High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b
Fanpu Ji, Jie Li, Li Liu, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 280) with videos related to
Sort By:
Page
of 28
Gut
|
June 24, 2025
Rice-derived recombinant human serum albumin as an alternative to human plasma for patients with decompensated liver cirrhosis: a randomised, double-blind, positive-controlled and non-inferiority trial
Junqi Niu, Yanhang Gao, Guiqiang Wang, et al.
Clinical and Molecular Hepatology
|
January 22, 2025
Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0
Di Wu, Jia-Horng Kao, Teerha Piratvisuth, et al.
EMBO Reports
|
July 10, 2020
The deubiquitinase USP44 promotes Treg function during inflammation by preventing FOXP3 degradation
Jing Yang, Ping Wei, Joseph Barbi, et al.
Scientific Reports
|
July 18, 2020
High prevalence of Clonorchis sinensis infections and coinfection with hepatitis virus in riverside villages in northeast China
Yanhang Gao, Yanqing Li, Xiaowen Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 6, 2021
Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 Trial
Yanhang Gao, Fei Kong, Xinwen Song, et al.
The Journal of Infection
|
February 23, 2025
Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trial
Mingyuan Zhang, Yanhang Gao, Fei Kong, et al.
Journal of Gastroenterology and Hepatology
|
October 5, 2013
Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection
Huiying Rao, Lai Wei, Juan Carlos Lopez-Talavera, et al.
Nature Medicine
|
November 7, 2025
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial
Grace Lai-Hung Wong, Man-Fung Yuen, Bingliang Lin, et al.
Emerging Microbes & Infections
|
November 18, 2022
Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China
Hongqin Xu, Hongyan Li, Hailong You, et al.
Journal of Gastroenterology and Hepatology
|
August 26, 2020
High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b
Fanpu Ji, Jie Li, Li Liu, et al.
Page
of 28